Biocogniv
Burlington
About Biocogniv
More than a decade since the HITECH Act established a timeline for EHR adoption, US hospitals today find themselves generating more clinical and administrative data on any given day than previously thought possible. Yet clinical operations are still based on subjective decision-making and traditional processes that ignore not only the raw data, but also the valuable efficiency improvements that can be automatically derived from them. Biocogniv picks up where the EHR transformation left off and introduces real-time intelligence on top of this vast backdrop of data, to improve the quality, cost, and ultimately access to care in US health systems.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.4M
- Last round: Series Unknown (Oct 2023)
- Website: biocogniv.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Machine Learning, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/biocogniv-115535 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.